Folinic acid antagonizes methotrexate-induced differentiation of monocyte progenitors

Rheumatology International

Volumn 22, Issue 2, 2002, Pages 60-67

  Kirkham, A P S ^a   Knight, S L ^a   Craggs, M D ^a   Casey, A T M ^a   Shah, P J R ^a  

^a ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

Differentiation; Folinic acid; Methotrexate; Monocyte; U937

Indexed keywords

ANTIRHEUMATIC AGENT; CALCITRIOL; CD11 ANTIGEN; CD14 ANTIGEN; FOLINIC ACID; METHOTREXATE; CD11B ANTIGEN; DACTINOMYCIN; FOLIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY; STEM CELL; ANTIINFLAMMATORY ACTIVITY; CELL ASSAY; CELL COUNT; CELL NUCLEUS; CELL PROLIFERATION; CELL SELECTION; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE CALCULATION; FLUORESCENCE; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

ANTIGENS, CD11; ANTIGENS, CD14; ANTIRHEUMATIC AGENTS; APOPTOSIS; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; FLOW CYTOMETRY; HUMANS; LEUCOVORIN; METHOTREXATE; MONOCYTES; STEM CELLS; TUMOR CELLS, CULTURED; HUMAN; SUPPORT, NON-U.S. GOV'T;

EID: 0035985382     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-002-0188-9     Document Type: Article

References (37)

1. Methotrexate use in rheumatoid arthritis. A clinician's perspective
2. Trends in the use of disease modifying an-tirheumatic medications in rheumatoid arthritis 1980-1995: Results from the national ambulatory medical care surveys
3. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis
4. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: An 8 week randomized placebo controlled trial
5. Guidelines for monitoring drug therapy in rheumatoid arthritis
6. Folic and folinic acid supplementation reduces methotrexate gastrointestinal side effects in rheumatoid arthritis
7. Daily folate supplementation is an adequate prophylaxis against met-hotrexate-induced nausea and vomiting and avoids the need for expensive anti-emetic prescription
8. The eBcacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials
9. Leflunomide versus methotrexate: A comparison of the European and American experience
10. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
11. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
12. Folic acid supplementation and methotrexate eBcacy: Comment on articles by Schiff Emery et al., and others
13. Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells
14. The effect of anti-rheumatic drugs on interleukin-1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes
15. Methotrexate: Mechanism of action in rheumatoid arthritis
16. The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis
17. Tumor necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis
18. Anti-inflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis
19. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment
20. The anti-inflammatory mechanism of methotrexate
21. Reversal of the anti-inflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: Evidence that the anti-inflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant induced arthritis
22. Anti-arthritic effect of methotrexate. Is it really mediated by adenosine?
23. Effect of methotrexate on blood purine and pyrimidine levels in patients with rheumatoid arthritis
24. Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes
25. Antiproliferative and anti-inflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis
26. Methotrexate action in rheumatoid arthritis: Stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells
27. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1β, and IL-8 - Markers of remission in rheumatoid arthritis during treatment with methotrexate
28. A proinflammatory role for IL-18 in rheumatoid arthritis
29. Interleukin-18 (IFN gamma-inducing factor) induces IL-8 and IL-1β via TNF alpha production from non-CD14(+) human blood mononuclear cells
30. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis
31. The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis
32. Reversal of methotrexate-induced folate pool depletion by thymidine in a human leukemia cell line in vitro
33. A rapid method for measuring apoptosis and dual colour immunofluorescence by single laser flow cytometry
34. Interleukin-18 expression and its monokine directed function in rheumatoid arthritis
35. Suppressive influences of methotrexate on the generation of CD14(+) monocyte-lineage cells from bone marrow of patients with rheumatoid arthritis
36. Clinical use of thymidine as a rescue agent from methotrexate toxicity
37. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1 beta are differentially regulated in human blood mononuclear cells and mouse spleen cells